Cover Image

歐洲的醫藥品、醫療產業 (季度更新報告)

Europe Pharmaceuticals and Healthcare Report Q4 2016

出版商 BMI Research 商品編碼 363589
出版日期 內容資訊 英文 38 Pages
商品交期: 最快1-2個工作天內
Back to Top
歐洲的醫藥品、醫療產業 (季度更新報告) Europe Pharmaceuticals and Healthcare Report Q4 2016
出版日期: 2016年10月19日 內容資訊: 英文 38 Pages

本報告提供歐洲各國的製藥產業及醫療產業相關分析,地區整體產業規模的實際成果值、預測值 (過去5年、今後10年份) 估計,產業的課題 (風險) 和未來性的商機 (利潤) 相關評估,域內各地區的詳細趨勢,主要企業簡介等資訊彙整,為您概述為以下內容


  • 歐洲市場最新形勢


  • 歐洲市場最新形勢


  • 醫藥品市場最新形勢
  • 醫療市場最新形勢


  • 歐洲:風險/利潤指標


  • 歐洲市場最新形勢


  • 歐洲市場最新形勢


  • 歐洲市場最新形勢



  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關註記
  • 風險/利潤指標技術
  • 指標概要
  • 指標的加權


Product Code: 2398-1024

BMI View: The growth outlook for pharmaceuticals and healthcare markets in Western and Emerging

Europe are divergent. While an ageing population will play a part in the heightening of demand, it is the

increase in healthcare access in Emerging Europe that will be the primary driver of robust growth. In

Western Europe, cost-containment measures will be prominent. Pharmaceutical sales will be driven by

generic drug substitution policies in Emerging Europe while in the more affluent countries of Western

Europe, demand for both patented and generic medicines will continue, albeit to a lesser extent.

Headline Expenditure Projections

Pharmaceuticals: USD309.0bn in 2015 to USD301.9bn in 2016; -2.3% in US dollar terms.

Healthcare: USD1,847bn in 2015 to USD1,815bn in 2016; -1.7% in US dollar terms.

Table of Contents

  • BMI Industry View
    • Table: Headline Regional Pharmaceuticals & Healthcare Forecasts (2014-2020)
  • SWOT
  • Europe - Q4 2016
  • Industry Forecast
  • Pharmaceutical Market Forecast
    • Table: Regional Pharmaceutical Sales, Historical Data And Forecasts (Europe 2012-2020)
  • Healthcare Market Forecast
    • Table: Regional Healthcare Expenditure Trends, Historical Data And Forecasts (Europe 2012-2020)
  • Industry Risk Reward Index
  • Market Overview
  • Industry Trend Analysis
  • Regional Themes
  • Industry Trends & Developments
  • Regional Round-Up
  • Glossary
  • Methodology
  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
  • Index Overview
    • Table: Pharmaceutical Risk/Reward Index Indicators
  • Indicator Weightings
Back to Top